Literature DB >> 160323

Plasma and urinary androgens in women with varying degrees of risk of breast cancer.

D Y Wang, J W Moore, B S Thomas, R D Bulbrook, S A Hoare, D Tong, J L Hayward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 160323     DOI： 10.1016/0014-2964(79)90253-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Androgen receptors, serum androgen levels and survival of breast cancer patients.

Authors:  M Langer; E Kubista; M Schemper; J Spona
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

2.  Effects of drugs associated with hyperprolactinemia on plasma steroids and on steroid receptors and metabolism in human breast cancer.

Authors:  R C Mason; W R Miller; R A Hawkins; M S Brown; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

3.  Low serum testosterone concentrations in patients with carcinoma of the pancreas.

Authors:  B Greenway; M J Iqbal; P J Johnson; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

4.  The relationship of urinary and plasma androgens to steroid receptors and menopausal status in breast cancer patients and their influence on survival.

Authors:  B H Mason; I M Holdaway; S J Skinner; R G Kay
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

5.  Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey.

Authors:  D Y Wang; D S Allen; B L De Stavola; I S Fentiman; J Brussen; R D Bulbrook; B S Thomas; J L Hayward; M J Reed
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.